Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Oncotherapy Plc LSE:AVO London Ordinary Share GB00BD6SX109 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.0% 35.50 35.00 36.00 35.50 35.00 35.00 20,083 08:00:10
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 0.0 -21.9 -9.8 - 124

Advanced Oncotherapy Share Discussion Threads

Showing 5376 to 5396 of 5475 messages
Chat Pages: 219  218  217  216  215  214  213  212  211  210  209  208  Older
DateSubjectAuthorDiscuss
17/7/2019
10:27
Is this company dead or what? No news, nothing...
sea and sky
12/6/2019
10:30
Even 100p only equates to 4p at the pre-reverse split price. The present share price equates less than 1p at the old prices. At one time it was close to 20p at the old prices. That would be almost 400p at the current prices. A lot of people bought at those prices and caught a massive cold when the BoD failed to keep their promises. They did the reverse split to make the share price look better. Even 20p looks a lot better than 0.8p.
daijavu
04/6/2019
19:00
I wouldn't be too happy with 100p. That's less than my average..
marvin66
03/6/2019
08:29
AVO now looks like a real target for one of the major players in this segment. a potential unicorn stand alone, i guess 100p will be needed to take this off current investors. looks increasingly good! "only" negative is that they are likely to require more funds if they are to complete the development fully on their own. high risk still, however upside tremendous.
baner
19/5/2019
15:39
ii will be increasing fees again from June 10th to £9.99 per month from £22.50 a quarter Its long overdue I took my business elsewhere. If anybody can recommend a cheaper broker let me know. I am considering going to iweb-sharedealing(Halifax) for a fixed £5 a trade or X-O(Jarvis) for £5.95, neither have monthly, yearly, or inactivity fees like ii
carlsagan1
18/5/2019
10:05
Thanks Metis. Very bullish comments from Goetzpartners. lets hope their £1.55 price target becomes reality.
jimbob58
17/5/2019
16:10
Any ideas on today’s move?
jimbob58
14/5/2019
13:21
imjustdandy, Please explain why you think there is no dilution when AVO has issued 5,862,500 new shares as part of the deal?
daijavu
12/5/2019
20:11
This will take off this week for sure.
imjustdandy
10/5/2019
11:39
Still looks a good deal with 40p and £1 subscription prices. Funded for 2 years without dilution. Will waken up next week
imjustdandy
10/5/2019
08:27
Pretty good deal. 40p and £1 subscription
imjustdandy
02/5/2019
11:26
cbd. Why don't you go away and stop cluttering up the boards. cbd filtered
daijavu
17/4/2019
15:03
Cynicism aside, there are issues about when AVO will achieve a revenue and move into profitability. AVO says that the first patient is expected to be treated by the end of 2020. On past showing, that might be overly optimistic because AVO has a track record of failing to meet its promised development targets. Even if that particular target is met, Moataz is just the latest occupant of his job. Even if he is all that is said, he may have an insurmountable task until LIGHT has been shown to work on a patient and AVO has shown that they can deliver LIGHT to their customers in accordance with any agreed timetable. I have my doubts. Even if all goes to plan, there might not be any revenue until around 21/22. AVO may not reach break even until two or thee years later with profitability being achieved a few years after that. That is around ten years down the road before shareholders might expect a return. imho, it is an investment that requires a lot of patience.
daijavu
16/4/2019
23:40
Come come twirl. Don't spoil the newbies' illusions. After all, one day AVO might surprise us all by actually doing what it says on the tin. I wonder how long it will be before the new crop of wannabee AVO millionaires realise that just because AVO says they are on track, it doesn't mean that they actually are.
daijavu
16/4/2019
22:24
Sorry wrong board
discodave4
16/4/2019
20:54
Lets hope so but at present no one wants to buy it. Unlike 3 yrs ago when orders were made and the then commercial director appointment bathed in blue sky which turned out to be a mirage.
twirl
16/4/2019
08:41
an excellent recruitment announced today. we are approaching commercial launching for this potential unicorn company!
baner
22/2/2019
20:33
The below is from Https://www.hardmanandco.com/wp-content/uploads/2019/01/AVO-ISO-approval-21-Jan-2019.pdf ► Strategy: AVO is developing a compact and modular PT system at an affordable price for the payor, financially attractive to the operator, and generating superior patient outcomes. AVO benefits from the technology know-how developed by CERN and ADAM, Geneva, and relies on a base of world-class suppliers. ► ISO approval: ISO 13485 is an internationally agreed standard that sets out the requirements for a quality management system specific to the medical devices industry. It can also be used by internal and external parties, such as certification bodies, to help them with their auditing processes. ► Development update: Infrastructure to support the installation and assembly of the full LIGHT system has already started at STFC’s Daresbury Laboratory. Once the complete system has been installed and validated, it will be used to support AVO’s submission for CE marking, prior to first patients in 2020. ► Risks: With the £10m funding announced in December, AVO is maintaining its ability to meet its objectives and keep the pace of its manufacturing plan. Execution risk remains, but the more complex technical challenges have been overcome, and integration of the remaining units is an easy step towards getting the LIGHT accelerator. ► Investment summary: Demand for PT is increasing worldwide, and the need for a small, flexible, affordable and close-to-patient system is desirable. AVO has attracted strong manufacturing and investment partners, and discussions with potential customers are advancing. Progress at the flagship Harley Street site has been substantial, and installation of the first LIGHT system is planned to start in mid-2019. The latest technical update has brought further assurance and boosted confidence. The previous Hardman report - Https://www.hardmanandco.com/wp-content/uploads/2018/10/AVO-Technical-update-16-October-2018.pdf
metis20
22/2/2019
18:47
Got a good feeling.
paul_98
22/2/2019
17:53
I hope you are right but, in my experience, the BoD do not feel much loyalty to their small private investors.
daijavu
22/2/2019
17:15
On the contrary I’m really pleased with how this is firming up. So much progress, so many more positives and a largely derisked investment. Very positive outlook. GLA. Loyalty and patience the key.
paul_98
Chat Pages: 219  218  217  216  215  214  213  212  211  210  209  208  Older
ADVFN Advertorial
Your Recent History
LSE
AVO
Advanced O..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210622 08:30:53